{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T13:08:53Z","timestamp":1745845733236,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP16K08559"],"award-info":[{"award-number":["JP16K08559"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Daiichi Sankyo Research Contribution Program 2018"},{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP17am0101122","JP18mk0104117j0001"],"award-info":[{"award-number":["JP17am0101122","JP18mk0104117j0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00380-019-01521-y","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T11:59:51Z","timestamp":1571399991000},"page":"593-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin\u2013dopamine antagonists against insomnia and nocturnal delirium"],"prefix":"10.1007","volume":"35","author":[{"given":"Ryuichi","family":"Kambayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko T.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"crossref","first-page":"e001568","DOI":"10.1161\/JAHA.114.001568","volume":"4","author":"CS Wu","year":"2015","unstructured":"Wu CS, Tsai YT, Tsai HJ (2015) Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc 4:e001568","journal-title":"J Am Heart Assoc"},{"key":"1521_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00023210-200115040-00006","volume":"15","author":"SV Onrust","year":"2001","unstructured":"Onrust SV, McClellan K (2001) Perospirone. CNS Drugs 15:329\u2013337","journal-title":"CNS Drugs"},{"key":"1521_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2165\/11202620-000000000-00000","volume":"24","author":"ED Deeks","year":"2010","unstructured":"Deeks ED, Keating GM (2010) Blonanserin: a review of its use in the management of schizophrenia. CNS Drugs 24:65\u201384","journal-title":"CNS Drugs"},{"key":"1521_CR4","unstructured":"Sumitomo Dainippon Pharma Co., Ltd. Blonanserin: Lonasen tablets 2\u00a0mg\/Lonasen tablets 4\u00a0mg\/Lonasen powder 2% common technical document 2.6.2 [In japanese] Available at: http:\/\/www.pmda.go.jp\/drugs\/2008\/P200800002\/index.html Accessed on March 5th, 2019"},{"key":"1521_CR5","first-page":"65","volume":"43","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Kanaji Y, Kida N, Takagi T, Inamura Y, Suzuki A, Kurihara K, Ono Y, Shimizu S, Otomo K, Isobe M (2011) A case of myotonic dystrophy who developed QT prolongation and torsade de pointes. Shinzo 43:65\u201372 (in Japanese)","journal-title":"Shinzo"},{"key":"1521_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","volume":"22","author":"Van de Water A, Verheyen J, Xhonneux R, Reneman RS","year":"1989","unstructured":"Van de Water A, Verheyen J, Xhonneux R, Reneman RS (1989) An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22:207\u2013217","journal-title":"J Pharmacol Methods"},{"key":"1521_CR7","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/bjp.2008.240","volume":"154","author":"A Sugiyama","year":"2008","unstructured":"Sugiyama A (2008) Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol 154:1528\u20131537","journal-title":"Br J Pharmacol"},{"key":"1521_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2131\/jts.41.439","volume":"41","author":"X Cao","year":"2016","unstructured":"Cao X, Nakamura Y, Wada T, Izumi-Nakaseko H, Ando K, Sugiyama A (2016) Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetizes beagle dogs. J Toxicol Sci 41:439\u2013447","journal-title":"J Toxicol Sci"},{"key":"1521_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/clpt.2014.155","volume":"96","author":"L Johannesen","year":"2014","unstructured":"Johannesen L, Vicente J, Mason JW, Sanabria C, Waite-Labott K, Hong M, Guo P, Lin J, S\u00f8rensen JS, Galeotti L, Florian J, Ugander M, Stockbridge N, Strauss DG (2014) Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Clin Pharmacol Ther 96:549\u2013558","journal-title":"Clin Pharmacol Ther"},{"key":"1521_CR10","first-page":"903","volume":"31","author":"E Satoh","year":"1997","unstructured":"Satoh E, Sugimoto S, Tsujimoto S, Nakahara H, Miyagishi A, Katoh T (1997) General pharmacological studies of perospirone hydrochloride (SM-9018) a novel antipsychotic agent. Kiso to Rinsho 31:903\u2013929 (in Japanese)","journal-title":"Kiso to Rinsho"},{"key":"1521_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1254\/jjp.54.478","volume":"54","author":"T Kato","year":"1990","unstructured":"Kato T, Hirose A, Ohno Y, Shimizu H, Tanaka H, Nakamura M (1990) Binding profile of SM-9018, a novel antipsychotic candidate. Jpn J Pharmacol 54:478\u2013481","journal-title":"Jpn J Pharmacol"},{"key":"1521_CR12","first-page":"1263","volume":"10","author":"T Une","year":"2007","unstructured":"Une T, Kurumiya S (2007) Pharmacological profile of blonanserin. Jpn J Clin Psychopharmacol 10:1263\u20131272 (in Japanese)","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"1521_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1113\/jphysiol.2006.121921","volume":"578","author":"G Thomas","year":"2007","unstructured":"Thomas G, Gurung IS, Killeen MJ, Hakim P, Goddard CA, Mahaut-Smith MP, Colledge WH, Grace AA, Huang CL (2007) Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J Physiol 578:85\u201397","journal-title":"J Physiol"},{"key":"1521_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0008-6363(96)00163-0","volume":"33","author":"MH Philips","year":"1997","unstructured":"Philips MH, Harper PS (1997) Cardiac disease in myotonic dystrophy. Cardiovasc Res 33:13\u201322","journal-title":"Cardiovasc Res"},{"key":"1521_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/0735-1097(88)91547-1","volume":"11","author":"HH Nguyen","year":"1988","unstructured":"Nguyen HH, Wolfe HT, Holmes DR, Edwards WD (1988) Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 11:662\u2013671","journal-title":"J Am Coll Cardiol"},{"key":"1521_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9343(79)90795-2","volume":"67","author":"J Motta","year":"1979","unstructured":"Motta J, Guilleminault C, Billinghem M, Barrow W, Mason J (1979) Cardiac abnormalities in myotonic dystrophy, electrophysiologic and histopathologic studies. Am J Med 67:467\u2013473","journal-title":"Am J Med"},{"key":"1521_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3988\/jcn.2013.9.3.186","volume":"9","author":"KM Park","year":"2013","unstructured":"Park KM, Shin KJ, Kim SE, Park J, Ha SY, Kim BJ (2013) Prolonged Corrected QT interval in patients with myotonic dystrophy type 1. J Clin Neurol 9:186\u2013191","journal-title":"J Clin Neurol"},{"key":"1521_CR18","first-page":"100","volume":"35","author":"V Russo","year":"2016","unstructured":"Russo V, Papa AA, Rago A, Ambrosio PD, Cimmino G, Palladino A, Politano L, Nigro G (2016) Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population. Acta Myol 35:100\u2013106","journal-title":"Acta Myol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01521-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01521-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T02:59:10Z","timestamp":1664679550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01521-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01521-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}